Itau Unibanco Holding S.A. Innoviva, Inc. Transaction History

Itau Unibanco Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $38,939 - $51,716	-3,389 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $45,099 - $84,694	-5,561 Reduced 62.13%	3,389 $40,000
Q4 2019 Feb 14, 2020	BUY	$10.28 - $14.38 $92,006 - $128,701	8,950 New	8,950 $127,000
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $232,969 - $337,283	-23,181 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $303,671 - $346,555	23,181 New	23,181 $338,000
Q4 2018 Feb 13, 2019	SELL	$13.96 - $18.26 $161,782 - $211,615	-11,589 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$13.63 - $15.7 $6,542 - $7,536	-480 Reduced 3.98%	11,589 $177,000
Q2 2018 Aug 13, 2018	BUY	$13.44 - $17.59 $162,207 - $212,293	12,069 New	12,069 $167,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.